| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.32B | +101.7% |
| Cost of Revenue | $684.9M | +78.9% |
| Gross Profit | $633.1M | +133.7% |
| R&D Expense | $1.7M | +325.0% |
| SG&A Expense | $366.8M | -14.4% |
| Operating Income | $266.4M | +268.8% |
| Pre-tax Income | $291.7M | +291.1% |
| Income Tax | $64.9M | +87.6% |
| Net Income | $226.8M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $756.0M | +23.1% |
| Accounts Receivable | $183.7M | +190.2% |
| Inventory | $229.3M | +32.3% |
| Current Assets | $1.20B | +31.3% |
| Total Assets | $1.54B | +25.7% |
| Current Liabilities | $276.6M | +71.5% |
| Total Liabilities | $447.9M | +25.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $141.2M | +30.5% |
| Capital Expenditures | $17.4M | +111.0% |
| Investing Cash Flow | -$14.2M | -150.4% |
| Financing Cash Flow | -$25.2M | -104.7% |
| Free Cash Flow | $123.8M | +23.9% |
| +221.1% |
| EPS (Basic) | $0.79 | +130.0% |
| EPS (Diluted) | $0.77 | +129.3% |
| Stockholders' Equity |
| $264.0M |
| +558.6% |